The global hospital acquired infection control market is on the rise, and it's not hard to see why. In 2021, the market was estimated to be worth a substantial $29.1 billion, and it's projected to reach an impressive $31.3 billion by 2026. This growth is underpinned by a steady compound annual growth rate (CAGR) of 1.5% from 2021 to 2026. So, what's driving this growth, and what are the challenges and opportunities in this industry?
Download PDF Brochure-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=204343466
Driving Factors
Several key factors are contributing to the expansion of the hospital acquired infection control market. The high incidence of hospital-acquired infections (HAIs) is a significant concern, and addressing this issue is driving the demand for infection control measures. The growing number of surgical procedures worldwide is also a driving force. With approximately 235 million major surgical procedures performed globally each year, the need for sterilization and infection control in healthcare settings is evident.
Additionally, the aging population and the increasing prevalence of chronic diseases are amplifying the importance of infection control in hospitals. Technological advancements in sterilization equipment and a heightened awareness of environmental and personal hygiene due to the COVID-19 pandemic are further fueling market growth.
Challenges Ahead
While the hospital acquired infection control market shows promise, it's not without its challenges. Concerns regarding the safety of reprocessed instruments are a limiting factor. Inadequate cleaning and sterilization of reusable medical devices can result in the retention of biological debris and increase the risk of surgical-site infections. These concerns have raised questions about the safety and performance of reprocessed devices, making their acceptance among healthcare providers and physicians more challenging.
Another challenge is the high cost of endoscope reprocessing and limited reimbursement in developing countries. End-user noncompliance with sterilization standards is yet another obstacle in this field. These challenges must be addressed to ensure effective infection control in healthcare facilities.
Opportunities for Growth
Despite the challenges, there are noteworthy opportunities in the hospital acquired infection control market. The reintroduction of ethylene oxide (EtO) sterilization is one such opportunity. EtO sterilization, although facing regulatory concerns due to its potential health and environmental risks, has seen increased adoption for sterilizing protective gear and single-use instruments during the COVID-19 pandemic. This technology plays a crucial role in ensuring the safety of medical products and devices.
Download PDF Brochure-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=204343466
Conclusion
The hospital acquired infection control market is in a state of growth and transformation. While challenges related to reprocessed instruments and regulatory concerns exist, opportunities such as the resurgence of EtO sterilization and the increased focus on infection control are propelling the industry forward. With the demand for sterilization and disinfection products and services continuing to rise, the hospital acquired infection control market remains a vital component of the global healthcare landscape. As it moves forward, addressing challenges and seizing opportunities will be key to its sustained growth and success.
